Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof

T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopeptides and methods of use thereof

US Patent 11718658 · Granted Aug 8, 2023

Estimated economic value: $2,338,000 ⓘ

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Multispecific binding constructs against checkpoint molecules and uses thereof2025
Anti-CTLA-4 antibodies and methods of use thereof2025
Anti-CD137 antibodies and methods of use thereof2025
T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopepti2025
T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopepti2025
T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopepti2025
T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopepti2025
T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopepti2025
T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopepti2025
T cell receptors that bind to mixed lineage leukemia (MLL)-specific phosphopepti2025
Anti-CTLA-4 antibodies and methods of use thereof2025
Antibodies that bind human C6 and uses thereof2025